ZA201601461B - Polymorphic form of pyrrole derivative and intermediate thereof - Google Patents
Polymorphic form of pyrrole derivative and intermediate thereofInfo
- Publication number
- ZA201601461B ZA201601461B ZA2016/01461A ZA201601461A ZA201601461B ZA 201601461 B ZA201601461 B ZA 201601461B ZA 2016/01461 A ZA2016/01461 A ZA 2016/01461A ZA 201601461 A ZA201601461 A ZA 201601461A ZA 201601461 B ZA201601461 B ZA 201601461B
- Authority
- ZA
- South Africa
- Prior art keywords
- polymorphic form
- pyrrole derivative
- pyrrole
- derivative
- polymorphic
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2828MU2013 IN2013MU02828A (forum.php) | 2013-08-29 | 2014-08-28 | |
| PCT/IN2014/000551 WO2015029066A1 (en) | 2013-08-29 | 2014-08-28 | Polymorphic form of pyrrole derivative and intermediate thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201601461B true ZA201601461B (en) | 2017-05-31 |
Family
ID=51947417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/01461A ZA201601461B (en) | 2013-08-29 | 2016-03-03 | Polymorphic form of pyrrole derivative and intermediate thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9951009B2 (forum.php) |
| EP (1) | EP3039011A1 (forum.php) |
| IN (1) | IN2013MU02828A (forum.php) |
| MX (1) | MX371021B (forum.php) |
| PH (1) | PH12016500394A1 (forum.php) |
| WO (1) | WO2015029066A1 (forum.php) |
| ZA (1) | ZA201601461B (forum.php) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX350611B (es) | 2011-01-31 | 2017-09-11 | Cadila Healthcare Ltd | Tratamiento para la lipodistrofia. |
| MX346943B (es) | 2013-04-22 | 2017-04-06 | Cadila Healthcare Ltd | Una nueva composición para esteatosis hepática no alcohólica (nafld). |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201636015A (zh) | 2013-07-05 | 2016-10-16 | 卡地拉保健有限公司 | 協同性組成物 |
| IN2013MU02470A (forum.php) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
| WO2016181409A1 (en) * | 2015-05-11 | 2016-11-17 | Cadila Healthcare Limited | Saroglitazar magnesium for the treatment of chylomicronemia syndrome - |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| EP3551180B1 (en) | 2016-12-09 | 2021-09-29 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
| EP3746180A4 (en) * | 2018-01-30 | 2021-06-23 | Kainos Medicine, Inc. | SALT FORMS OF AN ORGANIC COMPOUND |
| WO2020183379A1 (en) * | 2019-03-11 | 2020-09-17 | Cadila Healthcare Limited | Novel salts, crystalline forms and premix of hypolipidemic agent |
| US12201611B2 (en) * | 2020-07-24 | 2025-01-21 | Zydus Lifesciences Limited | Composition comprising high purity pyrrole derivative and method for preparation thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6713494B1 (en) * | 1996-08-28 | 2004-03-30 | Eli Lilly And Company | Amorphous benzothiophenes, methods of preparation and methods of use |
| CA2316841C (en) * | 1998-01-07 | 2007-11-20 | Meiji Seika Kaisha Ltd. | Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| SI20425A (sl) * | 1999-12-10 | 2001-06-30 | LEK tovarna farmacevtskih in kemi�nih izdelkov d.d. | Priprava amorfnega atorvastatina |
| US6514995B1 (en) | 2000-09-25 | 2003-02-04 | Advanced Research And Technology Institute, Inc. | Enediyne compounds and methods related thereto |
| US6627760B1 (en) * | 2001-06-25 | 2003-09-30 | Astrazeneca Ab | Amorphous compound |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US20040132743A1 (en) * | 2002-06-21 | 2004-07-08 | Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories, Inc. | Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (levocetirizine dihydrochloride) |
| HRP20020614A2 (en) * | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| CN1777586A (zh) * | 2003-01-27 | 2006-05-24 | 韩美药品株式会社 | 稳定的无定形樟脑磺酸氨氯地平、其制备工艺以及其口服给药的组合物 |
| US20040266787A1 (en) * | 2003-03-25 | 2004-12-30 | Dr. Reddy's Laboratories Limited | Novel amorphous form of [2-[4-[(4-chlorophenyl)-phenyl methyl]-1-piperazinyl]ethoxy]acetic acid and process for the preparation thereof |
| UA84881C2 (ru) * | 2003-09-03 | 2008-12-10 | Уайт | Аморфный 42-эфир рапамицина и 3-гидрокси-2-(гидроксиметил)-2-метилпропионовой кислоты и фармацевтическая композиция, содержащая его |
| AR052918A1 (es) * | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| EP1912730A2 (en) * | 2005-07-28 | 2008-04-23 | Isp Investments Inc. | Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| US20080085315A1 (en) * | 2006-10-10 | 2008-04-10 | John Alfred Doney | Amorphous ezetimibe and the production thereof |
| MX350611B (es) | 2011-01-31 | 2017-09-11 | Cadila Healthcare Ltd | Tratamiento para la lipodistrofia. |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
-
2014
- 2014-08-28 MX MX2016002612A patent/MX371021B/es active IP Right Grant
- 2014-08-28 WO PCT/IN2014/000551 patent/WO2015029066A1/en active Application Filing
- 2014-08-28 US US14/915,457 patent/US9951009B2/en active Active
- 2014-08-28 EP EP14802513.3A patent/EP3039011A1/en not_active Withdrawn
- 2014-08-28 IN IN2828MU2013 patent/IN2013MU02828A/en unknown
-
2016
- 2016-02-29 PH PH12016500394A patent/PH12016500394A1/en unknown
- 2016-03-03 ZA ZA2016/01461A patent/ZA201601461B/en unknown
-
2018
- 2018-04-06 US US15/947,049 patent/US20180297946A1/en not_active Abandoned
- 2018-04-06 US US15/947,044 patent/US20180297945A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015029066A1 (en) | 2015-03-05 |
| US20160207884A1 (en) | 2016-07-21 |
| US9951009B2 (en) | 2018-04-24 |
| EP3039011A1 (en) | 2016-07-06 |
| IN2013MU02828A (forum.php) | 2015-07-03 |
| PH12016500394A1 (en) | 2016-05-16 |
| MX371021B (es) | 2020-01-13 |
| MX2016002612A (es) | 2016-10-04 |
| US20180297946A1 (en) | 2018-10-18 |
| US20180297945A1 (en) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201601461B (en) | Polymorphic form of pyrrole derivative and intermediate thereof | |
| IL240788A0 (en) | Heterocyclic compounds and their uses | |
| ZA201602198B (en) | Preparation of hydroxy-benzylbenzene derivatives | |
| IL244084A0 (en) | New derivatives of onzialamycin and methods for their synthesis | |
| ZA201604502B (en) | Use of benzimidazole-proline derivatives | |
| GB201312318D0 (en) | Novel methods and compounds | |
| IL241290A0 (en) | Subprevir polymorphs and methods for their production | |
| GB2533513B (en) | Structure of pixel | |
| SG11201509753SA (en) | New polymorphic forms of icotinib phosphate and uses thereof | |
| SG11201509920UA (en) | Polymorphic forms of icotinib and uses thereof | |
| GB201309932D0 (en) | Novel pyrrole derivative | |
| GB201310126D0 (en) | Novel pyrrole derivatives | |
| GB201309935D0 (en) | Novel pyrrole derivatives | |
| GB201309960D0 (en) | Novel pyrrole derivatives | |
| TWM475821U (en) | Structure of mosquito-catch | |
| GB201309934D0 (en) | Novel pyrrole derivatives | |
| GB201309959D0 (en) | Novel pyrrole derivatives | |
| ZA201508950B (en) | New polymorphic forms of icotinib phosphate and uses thereof | |
| TWM475191U (en) | Structural improvement of hinge | |
| GB201300370D0 (en) | Method of calibrating asynchronies | |
| HUE041663T2 (hu) | Myxopyronin és származékai elõállítása | |
| GB201304054D0 (en) | Polymorphic form | |
| GB201304053D0 (en) | Polymorphic form | |
| GB201304055D0 (en) | Polymorphic form | |
| TWM476636U (en) | Improved structure of diabolo |